MedTrace Logo

Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus Nephritis

NCT01056237 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 206

Last updated 2015-07-31

No results posted yet for this study

Summary

An multi-site, randomized, prospective study to compare the efficacy and safety of multi-target therapy as continuous induction and maintenance treatment versus CTX- Aza therapy.

Conditions

Interventions

DRUG

Multi-target therapy

Tacrolimus (1-3mg/d) and mycophenolate mofetil(0.5-0.75g/d)

DRUG

Azathioprine

1.0-2.0mg/kg/d

Sponsors & Collaborators

  • Zhi-Hong Liu, M.D.

    lead OTHER

Principal Investigators

  • zhihong Liu, Master · Research Institute of Nephrology, Jinling Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01056237 on ClinicalTrials.gov